Singapore Approves Moderna’s First Bivalent COVID-19 Booster Jab
The Health Sciences Authority (HSA) of Singapore has granted interim authorisation for the use of Spikevax bivalent COVID-19 vaccine by Moderna, which targets both the original Sars-CoV-2 strain, and the Omicron BA.1 variant. The bivalent COVID-19 vaccine is authorized for use as a booster for people aged 18 years and above who have already received […]
Continue Reading